Delivery Order SPE2DB20D1100-SPE2DB24FD9A0

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD9A0
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,860,186 units of the pharmaceutical drug Fulvestrant 250 mg/5 ml syringe at a ceiling value of $1,141.16. The contract is a firm-fixed-price delivery order with a period of performance through September 2024. This award is not a set-aside contract. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide medical and pharmaceutical products to military treatment facilities, veterans' hospitals, and other government healthcare providers. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to hundreds of millions of dollars, to support the supply of critical care medical commodities to federal agencies and programs.

Generated 12/18/24, 9:02 AM